Peter Liese, an EU lawmaker and a member of Angela Merkel's party, in a statement called the decision as problematic and said the process followed by the European regulator EMA was better
Moderna, which created its shots with the US National Institutes of Health, said it got the final needed results over the weekend that suggest the vaccine is more than 94 percent effective
Moderna, Pfizer kick off late-stage COVID-19 vaccine trials; distribution in US by end-2020 a 'stretch goal'
Moderna said it could deliver some 500 million doses a year, and possibly up to 1 billion doses per year, starting in 2021.
COVID-19 research roundup: Multiple potential vaccines show promise; doctors say hands-only CPR safe during pandemic
Hands-only CPR carries low risk of transmitting COVID-19, and bystanders witnessing a cardiac arrest shouldn't be afraid to perform it, doctors say.
Damage to the membranes of red blood cells, which carry oxygen, could explain why many COVID-19 patients have alarmingly low oxygen levels.